Premium
Cytological reporting on lung FNA and small biopsy specimens in the era of personalized medicine
Author(s) -
MinoKenudson Mari
Publication year - 2017
Publication title -
cancer cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.29
H-Index - 57
eISSN - 1934-6638
pISSN - 1934-662X
DOI - 10.1002/cncy.21793
Subject(s) - medicine , subtyping , lung cancer , personalized medicine , fine needle aspiration , biopsy , pathology , precision medicine , lung , cytopathology , radiology , oncology , cytology , bioinformatics , computer science , biology , programming language
Because of the advancement of personalized medicine in lung cancer, the subtyping of non–small cell lung cancer and predictive biomarker testing with fine‐needle aspiration and biopsy specimens have never been more important. The pathologist needs to efficiently handle these small specimens, report the diagnosis/subtype in a clinically relevant format, and evaluate the tissue adequacy for molecular testing.